Shen JM, Zhao JY, Ye T, Gong LF, Wang HP, Chen WJ, Cai YK. Transanal minimally invasive surgery vs endoscopic mucosal resection for rectal benign tumors and rectal carcinoids: A retrospective analysis. World J Clin Cases 2020; 8(19): 4311-4319 [PMID: 33083390 DOI: 10.12998/wjcc.v8.i19.4311]
Corresponding Author of This Article
Yuan-Kun Cai, MD, Associate Professor, Chief Doctor, Department of General Surgery, Shanghai Fifth People’s Hospital, Fudan University, No. 801 Heqing Road, Shanghai 200240, China. 18918168583@163.com
Research Domain of This Article
Medicine, Research & Experimental
Article-Type of This Article
Case Control Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Oct 6, 2020; 8(19): 4311-4319 Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4311
Transanal minimally invasive surgery vs endoscopic mucosal resection for rectal benign tumors and rectal carcinoids: A retrospective analysis
Jia-Men Shen, Jia-Ying Zhao, Tao Ye, Li-Feng Gong, Hui-Peng Wang, Wen-Jie Chen, Yuan-Kun Cai
Jia-Men Shen, Jia-Ying Zhao, Tao Ye, Li-Feng Gong, Hui-Peng Wang, Wen-Jie Chen, Yuan-Kun Cai, Department of General Surgery, Shanghai Fifth People’s Hospital, Fudan University, Shanghai 200240, China
Author contributions: Shen JM designed and performed the research and wrote the manuscript; Zhao JY and Ye T designed the research and contributed to the analysis; Gong LF, Wang HP and Chen WJ provided clinical advice; Cai YK designed the research and supervised the report.
Supported bythe Science and Technology Commission of Shanghai Municipally, No. 17411967600.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the 5th People’s Hospital of Shanghai, Fudan University.
Informed consent statement: Patients were not required to give informed consent to the study because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: We have no financial relationships to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Yuan-Kun Cai, MD, Associate Professor, Chief Doctor, Department of General Surgery, Shanghai Fifth People’s Hospital, Fudan University, No. 801 Heqing Road, Shanghai 200240, China. 18918168583@163.com
Received: April 4, 2020 Peer-review started: April 4, 2020 First decision: June 18, 2020 Revised: July 1, 2020 Accepted: August 29, 2020 Article in press: August 29, 2020 Published online: October 6, 2020 Processing time: 176 Days and 9.1 Hours
ARTICLE HIGHLIGHTS
Research background
Transanal minimally invasive surgery (TAMIS) is a good choice for resection of benign lesions and carcinoids in the rectum. Endoscopic mucosal resection (EMR) is also widely used in the treatment of benign rectal tumors such as rectal polyps and rectal adenomas. However, no studies have compared the outcome of TAMIS and EMR.
Research motivation
We hope that this study will help surgeons in the choice of treatment for benign rectal lesions and rectal carcinoids.
Research objectives
We compared the short-term outcomes after TAMIS and EMR for rectal carcinoid and benign tumors (including rectal polyps and adenomas).
Research methods
The short-term outcomes after TAMIS and EMR for rectal carcinoids and benign tumors (including rectal polyps and adenomas) was compared.
Research results
TAMIS was associated with a higher urinary retention rate (13.6%, 6/44 vs 1.9%, 1/53 P = 0.026) and lower hemorrhage rate (0%, 0/44 vs 18.9%, 10/53 P = 0.002). A significantly higher reoperation rate was observed in the EMR group (9.4%, 5/53 vs 0%, 0/44 P = 0.036).
Research conclusions
Compared with EMR, TAMIS can remove rectal tumors more completely with effective hemostasis and lower postoperative hemorrhage and reoperation rates. TAMIS is a better choice for the treatment of rectal carcinoids and benign rectal tumors with a large diameter.
Research perspectives
TAMIS surgery requires more surgical instruments, a larger surgical field, deeper and more thorough tumor resection, more effective hemostasis and results in lower hemorrhage and reoperation rates. It is a better choice for the treatment of rectal carcinoids.
